Latest Breaking News On - Declining cost - Page 4 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products. Emerging markets in Asian countries and the rising focus on personalized medicine & protein therapeutics are other factors expected to offer strong growth opportunities for players in the recombinant proteins market. In contrast, the declining cost of recombinant proteins may restrict market growth to a certain extent.

United statesCellgenix gmbLaura woodBiotechnology companiesBioscience incSino biological incProteintech group incRd expenditure in pharmaceutical biotechnology companiesMerck kgaAviva systems biology corporationRaybiotech incPorter five forces analysisTechnogene ltdEnzo life sciences incPeprotech incOffice hours call